Indefinite Delivery Contract 75F40118D10169

The federal contract IDV was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to the University of Texas at Austin, a public research university. The single-award indefinite delivery contract, valued at $1,154,732.00, aims to evaluate batch-to-batch variability and its origins in dry powder inhalers. The contract has an ultimate completion date of March 31, 2023. The University of Texas at Austin, which is part of the larger University of Texas System, has an extensive track record of performing research and providing professional services to various federal agencies, including the Department of Defense, Department of Energy, National Science Foundation, NASA, and National Institutes of Health. The university leverages its expertise across diverse scientific and technical domains to deliver research, consulting, and other services under both prime contracts and subcontracts. This specific IDV contract with the FDA builds upon UT Austin's capabilities in areas such as aerospace engineering, materials science, and sensor technology, which the university has previously applied to federal programs like the DARPA-funded development of embedded, chipless Radio Frequency Identification (RFID) sensors for structural health monitoring of additively manufactured parts.